(+/-)-6-Benzo[b]thiophen-2-yl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole hydrochloride

ID: ALA3092296

PubChem CID: 72737032

Max Phase: Preclinical

Molecular Formula: C13H13ClN2S2

Molecular Weight: 260.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.c1ccc2sc(C3CN4CCSC4=N3)cc2c1

Standard InChI:  InChI=1S/C13H12N2S2.ClH/c1-2-4-11-9(3-1)7-12(17-11)10-8-15-5-6-16-13(15)14-10;/h1-4,7,10H,5-6,8H2;1H

Standard InChI Key:  JNKSOLVXNYVFGI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   23.3199   -5.3846    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   22.7759   -6.4395    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.9912   -6.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9912   -7.5216    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7759   -7.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2607   -7.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2065   -6.4395    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.7216   -7.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2065   -7.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6271   -6.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6271   -7.5216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4118   -7.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8965   -7.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4118   -6.4395    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.9111   -7.9342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1993   -7.5216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1993   -6.6966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9111   -6.2841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  2  6  1  0
  7  8  1  0
  8  9  1  0
  3  7  2  0
  4  9  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 10 14  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 10 18  2  0
 11 15  2  0
  8 13  1  0
M  END

Associated Targets(Human)

SAOS-2 (672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MG-63 (795 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALPI Tchem Intestinal alkaline phosphatase (724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALPP Tbio Alkaline phosphatase placental type (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 260.39Molecular Weight (Monoisotopic): 260.0442AlogP: 3.36#Rotatable Bonds: 1
Polar Surface Area: 15.60Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.74CX LogP: 3.37CX LogD: 3.28
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.78Np Likeness Score: -1.06

References

1. Debray J, Chang L, Marquès S, Pellet-Rostaing S, Le Duy D, Mebarek S, Buchet R, Magne D, Popowycz F, Lemaire M..  (2013)  Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests.,  21  (24): [PMID:24183741] [10.1016/j.bmc.2013.09.053]

Source